These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23473878)

  • 1. Effect of an mGlu2/3 receptor antagonist on depressive behavior induced by withdrawal from chronic treatment with methamphetamine.
    Iijima M; Koike H; Chaki S
    Behav Brain Res; 2013 Jun; 246():24-8. PubMed ID: 23473878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats.
    Koike H; Chaki S
    Behav Brain Res; 2014 Sep; 271():111-5. PubMed ID: 24909673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ketamine and LY341495 on the depressive-like behavior of repeated corticosterone-injected rats.
    Koike H; Iijima M; Chaki S
    Pharmacol Biochem Behav; 2013 Jun; 107():20-3. PubMed ID: 23578563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats.
    Liechti ME; Markou A
    Eur J Pharmacol; 2007 Jan; 554(2-3):164-74. PubMed ID: 17113075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The selective mGlu2/3 receptor antagonist LY341495 exacerbates behavioral signs of morphine withdrawal and morphine-withdrawal-induced activation of locus coeruleus neurons.
    Rasmussen K; Hsu MA; Vandergriff J
    Neuropharmacology; 2004 Apr; 46(5):620-8. PubMed ID: 14996539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The preferential mGlu2/3 receptor antagonist, LY341495, reduces the frequency of spike-wave discharges in the WAG/Rij rat model of absence epilepsy.
    Ngomba RT; Biagioni F; Casciato S; Willems-van Bree E; Battaglia G; Bruno V; Nicoletti F; van Luijtelaar EL
    Neuropharmacology; 2005; 49 Suppl 1():89-103. PubMed ID: 16043198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression.
    Koike H; Fukumoto K; Iijima M; Chaki S
    Behav Brain Res; 2013 Feb; 238():48-52. PubMed ID: 23098797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists.
    Koike H; Iijima M; Chaki S
    Neuropharmacology; 2011 Dec; 61(8):1419-23. PubMed ID: 21903115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term imipramine withdrawal induces a depressive-like behaviour in the forced swimming test.
    D'Aquila PS; Panin F; Serra G
    Eur J Pharmacol; 2004 May; 492(1):61-3. PubMed ID: 15145707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabotropic glutamate 2/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice.
    Ago Y; Yano K; Araki R; Hiramatsu N; Kita Y; Kawasaki T; Onoe H; Chaki S; Nakazato A; Hashimoto H; Baba A; Takuma K; Matsuda T
    Neuropharmacology; 2013 Feb; 65():29-38. PubMed ID: 23022081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The group II mGlu receptor antagonist LY341495 induces a rapid antidepressant-like effect and enhances the effect of ketamine in the chronic unpredictable mild stress model of depression in C57BL/6J mice.
    Pałucha-Poniewiera A; Podkowa K; Rafało-Ulińska A
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jul; 109():110239. PubMed ID: 33400944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of the metabotropic glutamate (mGlu) 2 receptor attenuates the MK-801-induced increase in the immobility time in the forced swimming test in rats.
    Kawaura K; Karasawa J; Hikichi H
    Pharmacol Rep; 2016 Feb; 68(1):80-4. PubMed ID: 26721357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of environmental enrichment during induction of methamphetamine dependence on the behavioral withdrawal symptoms in rats.
    Hajheidari S; Miladi-Gorji H; Bigdeli I
    Neurosci Lett; 2015 Sep; 605():39-43. PubMed ID: 26275348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of serotonin (5-HT)2 receptor ligands on depression-like behavior during nicotine withdrawal.
    Zaniewska M; McCreary AC; Wydra K; Filip M
    Neuropharmacology; 2010 Jun; 58(7):1140-6. PubMed ID: 20153341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of intracellular calcium release induces an antidepressant-like effect in the mouse forced swimming test.
    Galeotti N; Bartolini A; Ghelardini C
    Neuropharmacology; 2006 Mar; 50(3):309-16. PubMed ID: 16249008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral characterization of the mGlu group II/III receptor antagonist, LY-341495, in animal models of anxiety and depression.
    Bespalov AY; van Gaalen MM; Sukhotina IA; Wicke K; Mezler M; Schoemaker H; Gross G
    Eur J Pharmacol; 2008 Sep; 592(1-3):96-102. PubMed ID: 18634781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Group II metabotropic glutamate receptor blockade promotes stress resilience in mice.
    Highland JN; Zanos P; Georgiou P; Gould TD
    Neuropsychopharmacology; 2019 Sep; 44(10):1788-1796. PubMed ID: 30939596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the use-dependent, nicotinic receptor antagonist BTMPS in the forced swim test and elevated plus maze after cocaine discontinuation in rats.
    Hall BJ; Pearson LS; Buccafusco JJ
    Neurosci Lett; 2010 Apr; 474(2):84-7. PubMed ID: 20226229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Withdrawal from chronic treatment with methamphetamine induces anxiety and depression-like behavior in mice.
    Ru Q; Xiong Q; Zhou M; Chen L; Tian X; Xiao H; Li C; Li Y
    Psychiatry Res; 2019 Jan; 271():476-483. PubMed ID: 30544074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.